PubRank

Dexamethasone intravitreal implants in the management of tubercular multifocal serpiginoid choroiditis.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27576870)

Published in J Ophthalmic Inflamm Infect on August 30, 2016

Authors

Alex Fonollosa1,2, Sonia Valsero3, Joseba Artaraz3, Ioana Ruiz-Arruza4

Author Affiliations

1: Department of Ophthalmology, BioCruces Health Research Institute, Cruces Hospital, University of the Basque Country, Bilbao, Spain. afonollosacalduch@gmail.com.
2: Department of Ophthalmology, Cruces University Hospital, Plaza de Cruces s/n, Cruces-Barakaldo, CP 48903, Vizcaya, Spain. afonollosacalduch@gmail.com.
3: Department of Ophthalmology, BioCruces Health Research Institute, Cruces Hospital, University of the Basque Country, Bilbao, Spain.
4: Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Cruces Hospital, University of the Basque Country, Bilbao, Spain.

Articles cited by this ↗

Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages. Clin Exp Immunol (1989) 3.09

Rifampicin reduces effectiveness and bioavailability of prednisolone. Br Med J (Clin Res Ed) (1983) 1.79

Infectious nontuberculous serpiginous choroiditis. Arch Ophthalmol (2012) 1.52

Continuous progression of tubercular serpiginous-like choroiditis after initiating antituberculosis treatment. Am J Ophthalmol (2011) 1.14

Tubercular serpiginous-like choroiditis presenting as multifocal serpiginoid choroiditis. Ophthalmology (2012) 1.13

Multicenter study of intravitreal dexamethasone implant in noninfectious uveitis: indications, outcomes, and reinjection frequency. Am J Ophthalmol (2014) 1.09

Progressive ocular inflammation following anti-tubercular therapy for presumed ocular tuberculosis in a high-endemic setting. Eye (Lond) (2013) 1.01

Intravitreal methotrexate in the management of presumed tuberculous serpiginous-like choroiditis. Retina (2013) 0.92

SAFETY AND EFFICACY OF INTRAVITREAL DEXAMETHASONE IMPLANTS IN THE MANAGEMENT OF MACULAR EDEMA SECONDARY TO INFECTIOUS UVEITIS. Retina (2016) 0.83